发明名称 METHOD OF JUDGING MALIGNANCY OF A MAMMALIAN CANCER CELL
摘要 <p>A CDK profile including a ratio of specific activities of two cyclin dependent kinases closely correlates with the malignancy grade and the presence/absence of the sensitivity to an irritant such as an anticancer agent of a cancer tissue in clinical medicine. Therefore, the properties of a mammalian cell, such as malignancy grade, proliferation potency, sensitivity to an irritant such as an anticancer agent can be assessed based on its CDK profile or by comparing the result of a specific activity ratio of two CDKs with a predetermined threshold corresponding to the ratio. This sensitivity assessing method shows a high ratio of correct assessing results particularly in positive or sensitivity and is useful in predicting efficacy of chemotherapy using the anticancer agent.</p>
申请公布号 EP1767647(B1) 申请公布日期 2010.11.24
申请号 EP20050743830 申请日期 2005.05.30
申请人 SYSMEX CORPORATION 发明人 ISHIHARA, HIDEKI;MATSUSHIMA, TOMOKO;KAWASAKI, YUKO
分类号 G01N33/50;C12Q1/02;C12Q1/48;G01N33/15;G01N33/574 主分类号 G01N33/50
代理机构 代理人
主权项
地址